197 related articles for article (PubMed ID: 11434878)
1. Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil.
Koifman S; Jorge Koifman R
Breast Cancer Res; 2001; 3(4):270-5. PubMed ID: 11434878
[TBL] [Abstract][Full Text] [Related]
2. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
[TBL] [Abstract][Full Text] [Related]
3. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
[TBL] [Abstract][Full Text] [Related]
4. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
5. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
[TBL] [Abstract][Full Text] [Related]
6. Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer.
Gershoni-Baruch R; Dagan E; Fried G; Bruchim Bar-Sade R; Sverdlov-Shiri R; Zelicksson G; Friedman E
Eur J Cancer; 2000 May; 36(8):983-6. PubMed ID: 10885601
[TBL] [Abstract][Full Text] [Related]
7. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
[TBL] [Abstract][Full Text] [Related]
8. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
[TBL] [Abstract][Full Text] [Related]
9. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
Foulkes WD; Chappuis PO; Wong N; Brunet JS; Vesprini D; Rozen F; Yuan ZQ; Pollak MN; Kuperstein G; Narod SA; Bégin LR
Ann Oncol; 2000 Mar; 11(3):307-13. PubMed ID: 10811497
[TBL] [Abstract][Full Text] [Related]
10. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
Gilbert F; Dabney MK; Diemer K; Ludwig S; Rosenthal G; Osborne MP
Ann N Y Acad Sci; 1997 Dec; 833():198-203. PubMed ID: 9616755
[No Abstract] [Full Text] [Related]
12. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
Warner E; Foulkes W; Goodwin P; Meschino W; Blondal J; Paterson C; Ozcelik H; Goss P; Allingham-Hawkins D; Hamel N; Di Prospero L; Contiga V; Serruya C; Klein M; Moslehi R; Honeyford J; Liede A; Glendon G; Brunet JS; Narod S
J Natl Cancer Inst; 1999 Jul; 91(14):1241-7. PubMed ID: 10413426
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.
Schubert EL; Mefford HC; Dann JL; Argonza RH; Hull J; King MC
Genet Test; 1997; 1(1):41-6. PubMed ID: 10464624
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
[TBL] [Abstract][Full Text] [Related]
15. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
[TBL] [Abstract][Full Text] [Related]
16. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
17. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
Krainer M; Silva-Arrieta S; FitzGerald MG; Shimada A; Ishioka C; Kanamaru R; MacDonald DJ; Unsal H; Finkelstein DM; Bowcock A; Isselbacher KJ; Haber DA
N Engl J Med; 1997 May; 336(20):1416-21. PubMed ID: 9145678
[TBL] [Abstract][Full Text] [Related]
18. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
Kreiss Y; Barak F; Baruch RG; Levy-Lahad E; Pras E; Friedman E
Genet Test; 2000; 4(4):403-7. PubMed ID: 11216667
[TBL] [Abstract][Full Text] [Related]
19. The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
Hubert A; Peretz T; Manor O; Kaduri L; Wienberg N; Lerer I; Sagi M; Abeliovich D
Am J Hum Genet; 1999 Sep; 65(3):921-4. PubMed ID: 10441598
[No Abstract] [Full Text] [Related]
20. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
Nastiuk KL; Mansukhani M; Terry MB; Kularatne P; Rubin MA; Melamed J; Gammon MD; Ittmann M; Krolewski JJ
Prostate; 1999 Aug; 40(3):172-7. PubMed ID: 10398279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]